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is that it ensures the initiation of T cell activation withinConduit for Privileged
a few hours of antigen exposure rather than a day laterCommunications after the arrival of migrating DC.
One particularly interesting issue that is raised in thisin the Lymph Node
paper is how the conduit-associated DC is positioned
to acquire antigen from the FRCC. Sixt and colleagues
used immunofluorescence to characterize the extracel-A study by Sixt et al. in this issue of Immunity identifies
lular matrix components and integrins that FRC use toconduit-associated dendritic cells whose privileged
lie upon and invest the FRCC. Fluorescent-labeled ER-access to antigen arriving by the conduit enables up-
TR7, which allows one to see the FRC cytoplasm andtake andprocessing of antigenwithin 90minof antigen
an extracellular component, and fluorescent antibody toinoculation, long before the arrival of dendritic cells
perlecan, which allows one to see basementmembrane,from skin.
were used in combinationwith soluble fluorescent tracer
to show that DC membranes interrupted the FRC cyto-The cortex of lymph nodes is like a railway grand con-
plasm and, thus, were in direct contact with the conduitcourse through which traveling T- and B-lymphocytes
conducting the soluble antigen. This clearly demon-encounter antigen presented by dendritic cells and re-
strated that some DC were positioned to be able tospond by becoming activated or by dividing to produce
sample and present antigenic conduit contents. Figure 1daughter effector populations. Lymph node function de-
provides electron-microscopic images that complementpends on an extraordinary architectural scaffolding that
their data. The structure of the conduit can be viewedsolves daunting logistical challenges, in part by trans-
as a four-layer structure composed (from the center out)mitting soluble information through the very same reticu-
of: (1) a core of type I and III collagen bundles; thelar fibers that provide essential structural support for
void volume between bundles is the space in whichthe blood and lymph vasculature that are the portals for
chemokine and soluble antigen is transported; (2) a mi-hematopoietic cell entry and exit (Anderson and Shaw,
crofibrillar zone that is composed in large part of fibril-1993). The lymphocytes and mononuclear cells making
lins; this layer is unusually well visualized in Figure 1Bup the bulk of lymph node occupants are transient visi-
but is typically not well seen on EM and may mergetors that arrive and move through labyrinthine corridors
with the interior surface of the basement membrane thatand along reticular cell escalators to compartments
surrounds it; (3) basement membrane, in which lamininswhere theymay interactwith specific antigen presenting
8 and 10, perlecan, and type IV collagen are highly abun-cells, depending on their phenotype and functional role
dant; it is thus similar to endothelial basement mem-in immune responses. In this issue of Immunity, Michael
brane and thus capable of providing a sufficient seal toSixt and his colleagues reveal that the fibroblastic reticu-
prevent leakage on its own; (4) and fibroblastic reticular
lar cell conduit (FRCC) telegraphs privileged communi-
cells whose bodies form an additional circumferential
cations across the crowded lymph node cortex to den-
seal. Given this specialized seal around the conduit core,
dritic cells (DC), adding a new function to the known how can fluid-borne material exit? Hayakawa and col-
role of the FRCC in transmitting signals to the high endo- leagues demonstrated that macrophages and DC tightly
thelial venule (HEV) (Gretz et al., 2000). contact 10% of the conduit surface area (Hayakawa et
Sixt and colleagues identify a subset of dendritic cells al., 1988). Our own studies confirm such interactions
that has three cardinal properties: these DC are in direct and indicate that specialized contact regions (Figure 1C)
contact with the conduit, they appear to take up anti- can enable direct access of the conduit-associated DC
genic-tracer from the conduit, and they can process the to fluid in the conduit core (Gretz et al., 1996, 2000;
antigen thus acquired. Sixt and colleagues refer to these Kaldjian et al., 2001). These associated DC may be lost
DC variously as “conduit associated,” “fiber associ- during specimen processing, thereby giving rise to ap-
ated,” or “resident.” For use herein, we choose their parent “gaps” in the conduit covering. By occupying
term “conduit-associated” DC as the most useful func- and sealing the “gap” in the FRC, these DC receive,
tional description. They distinguish those DC from other process, and present soluble antigens without leaking
DC present nearby that are not in direct contact with antigen to all other lymph node occupants.
the conduit and do not rapidly acquire/process antigen A second issue that is certain to be complex and
present in the conduit. These findings confirm and ex- controversial is the origin and phenotype of the relevant
tend previous demonstrations of uptake/presentation of DC. Conduit-associated DC are likely to correspond to
antigen by lymph node DC at early time points after morphologically defined “interdigitating dendritic cells”
immunization. For example, Itano and colleagues identi- (IDC) which are found in T cell cortex and typically asso-
fied populations of DC in lymph nodes that mediate ciatedwith conduits. However, IDCare themselves com-
rapid uptake of antigen (peak 2 hr) (Itano et al., 2003). plex, consisting of at least four different phenotypes in
Prior to such findings, a prevailing view was that the tonsil (Summers et al., 2001) and presumably differing
relevant DC were ones that brought antigen from the in origin. The phenotypic data on DC in lymph node that
site of immunization to lymph node cortex, a process become antigen positive within a few hours of antigen
that takes about 24 hr. The compelling appeal of the inoculation is already somewhat contradictory. Sixt and
colleagues phenotype these cells by fluorescence mi-conduit-facilitated antigen delivery to lymph node DC
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Figure 1. Transmission Electron Micrographs
of Views of a Conduit
(A) The conduit is cut across the fiber reveal-
ing individual collagen fibers (asterisk) as
spots of two sizes; the larger are type I colla-
gen, and the smaller are type III collagen. Col-
lagen fibers are separated from each other by
space held open by cross bridges of keratan
sulfate and possibly other ECM proteogly-
cans. The gray amorphous material (f) along
the perimeter of the collagen core corre-
sponds to both the basement membrane and
fibrillin components, because they cannot be
distinguished in cross-sections. The entire
conduit is surrounded by a fibroblastic reticu-
lar cell (FRC); a junctional complex is visible
at the left where the two sides of the FRC
meet, thereby providing a cell-based water
tight seal that augments the seal provided by
basement membrane.
(B) The conduit is cut longitudinally just inside
of the perimeter of the fiber. This grazing cut
exaggerates the fibrillin layer (f) that can be
seen on either side of the collagen fibers (as-
terisk).
(C) Cross cut of a conduit with large collagen
core (asterisk) supporting a dendritic cell
(DC). In the upper left, around ten o’clock, a
process of the DC (arrow) can be seen in-
serting itself between the separated edges of
the two sides of the FRC process (FRC). The
preparation is from an adjuvant inoculation
study where significant numbers of dendritic
cells entered the lymph node from the blood
and inoculation site, and, therefore, presum-
ably this is a “differentiating” dendritic cell
that is initiating a firm connection to the
conduit.
croscopy as CD11bCD11c, DEC205 and conclude peri-HEV region populated by such dendritic cells. Re-
cently, in vitro binding assays on lymph node frozenthat these are myeloid dendritic cells that presumably
had previously entered lymph node from the blood. To sections were used by Katakai and colleagues to show
that a T cell area of lymph node cortex that is rich infurther characterize differential adhesion capacities of
such cells, they study in vitro bonemarrow-derived den- FRCC exhibited preferential binding of DC. They named
this area the “cortical ridge” (Katakai et al., 2004).dritic cells. In contrast, Jenkins and colleagues deter-
mine that the dendritic cells that become antigen posi- Thus, the immune system provides at least a dual
strategy for antigen processing and presentation by DCtive by 2 hr after subcutaneous inoculation are MHC
class IIhi and conclude that such DC originate from the in the lymph node; both strategies are strongly facili-
tated by strategic anatomic organization. A very earlyskin (Ingulli et al., 2002; Itano et al., 2003). Given techni-
cal differences (phenotyping by flow cytometry of recov- wave of antigen is delivered to conduit-associated DC
that initiates T cell stimulation resulting in both T cellered cells versus immunofluorescence analysis of cells
in situ) and experimental differences (e.g., footpad ver- activation (reflected in CD69 expression) and cytokine
secretion (for example, IL-2). DC from skin arrive aboutsus ear inoculation), firm conclusions on the origins of
such conduit-associated DC must await further investi- 24 hr later bearing much higher concentrations of anti-
gen; they efficiently position themselves near the HEVgation.
Another recent report is pertinent to discussion of how to maximize contact with incoming T cells. The stimulus
provided by such migratory dendritic cells provides ad-lymph node architecture facilitates antigen presentation
by dendritic cells. Using adoptive transfer of fluorescent ditional activation that results in sustained IL-2R expres-
sion and efficient promotion of delayed type hypersensi-transgenic cells, Bajenoff and coworkers described
preferential localization of tissue-derived dendritic cells tivity (Itano et al., 2003). The dynamics of T cell/dendritic
cell interactions in vivo are now the subject of intense in-near HEV (Bajenoff et al., 2003). They demonstrated that
resulting T cell activation clusters are enriched in the vestigation.
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interaction, which would typically be shown in a cell-Oxidative Modification of
free reconstitution assay. In fact, circumstantial evi-Leukocyte Adhesion dence presented in Stolen et al. (2005) suggests that it
is indeed the enzymatic activity of AOC3 that matters for
its function. First, all AOC3 antibodies with antiadhesive
properties also block its enzymatic activity. Second, if an
In this issue of Immunity, Marko Salmi and colleagues adhesion molecule is blocked by immunoneutralization,
describemice lackingAOC3, an endothelial cellmono- the effect is observed immediately, but injecting AOC3
aminooxidase that is involved in modulating leukocyte antibodies into mice raises leukocyte rolling velocity
rolling, adhesion, and migration (Stolen et al., 2005). over a 30 min period (Figure 4A in Stolen et al. [2005]),
Their data demonstrate the importance of oxidative consistent with a requirement for protein turnover that
modification of (unknown) adhesion molecules in reg- might remove an enzymatic modification. Indeed, the
ulating inflammation and lymphocyte homing. data suggest that selectin ligands may be targets of
enzymatic regulation. Neutrophil rolling velocity is in-
creased 5- to 6-fold in a model of cytokine-inducedAmino oxidase, copper-containing-3 (AOC3), also known
inflammation in venules of the cremaster muscle (Stolenas vascular adhesion molecule-1 (VAP-1), is an ectoen-
et al., 2005). This is reminiscent of the phenotype seenzyme that is constitutively expressed in adipocytes and
in E-selectin-deficient mice (Kunkel and Ley, 1996).endothelial and smooth muscle cells of most organs of
E-selectin engagement not only modulates leukocytemice and humans (Jalkanen and Salmi, 2001). Activity
rolling velocity, but also activates rolling neutrophilsis also found in blood serum, suggesting that the enzyme
(Simon et al., 2000) and results in their adhesion onmay be shed from the endothelial surface. AOC3 cata-
inflamed endothelial cells. This activation pathway islyzes oxidative deamination and produces aldehyde
redundant with chemokine-dependent neutrophil acti-groups, hydrogen peroxide, and ammonium. Although
vation, such that neutralizing chemokine receptor sig-enzymatic modifications of adhesion molecules are
naling or removing the chemokine receptor CXCR2 incommon, modification by an amino oxidase has not
mice has no effect on neutrophil recruitment unlessbeen described. Using gene targeting and homologous
E-selectin is also blocked (Smith et al., 2004). E-selectinrecombination, the authors have produced mice that
engages an unknown ligand to activate rolling neutro-lack detectable AOC3 activity from all organs tested
phils that is different from L-selectin or P-selectin Gly-(Stolen et al., 2005). Although these mice are viable and
coprotein Ligand-1 (Smith et al., 2004). Conceivably,healthy under vivariumconditions, they show interesting
absence of AOC3 impairs the neutrophil-activating ca-defects in lymphocyte homing and in the inflammatory
pacity of this interaction, which might explain the defectresponse to cytokine or autoimmune challenges. In
in neutrophil adhesion seen after 3 or 6 hr of TNF- (Stolenshort-term homing assays, AOC3/mice show reduced
et al., 2005). Slow neutrophil rolling and subsequent adhe-lymphocyte homing to mesenteric lymph nodes (MLN)
sion in inflammation requires not onlyE-selectinbut also2and spleen, which also show slightly reduced cellularity.
integrins (CD18) (Jung et al., 1998). 2 integrin-dependentWhat exactly does AOC3 do? As originally proposed,
slow neutrophil rolling is prominent when these integrinsAOC3may directly serve as an adhesionmolecule, bind-
are stabilized in a partially activated conformation (Salasing an unknown ligand (Salmi and Jalkanen, 1992). How-
ever, there are no data supporting suchadirect adhesive et al., 2004) or when their I-domain is expressed in isola-
